A Closer Look at Nancy Pelosi’s Plan for Lower Drug Prices

The bill, H.R. 3, has gotten considerably stronger from its initial concept, but questions remain.


You can count on the Prospect, can we count on you?

There's no paywall here. Your donations power our newsroom as we report on ideas, politics and power — and what’s really at stake as we navigate another presidential election year. Please, become a member, or make a one-time donation, today. Thank you!